MyFinsight
Home
Blog
About
NRX Pharmaceuticals, Inc. (NRXP)
NRX Pharmaceuticals, Inc. (NRXP)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$19,973K
Free Cash flow
-$9,772K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Proceeds from issuance of common...
Change in fair value of warrant ...
Others
Negative Cash Flow Breakdown
Net loss
Prepaid expense and other assets
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents at beginning of period
-
-
-
1,443
Net loss
-16,520
-1,430
360
-5,890
Depreciation and amortization expense
71
63
42
28
Amortization of operating right of use assets
102
102
58
15
Stock-based compensation
139
151
81
68
Common stock issued in exchange for services
972
-
1
450
Provision (recovery) for expected credit losses
25
28
40
-
Change in fair value of warrant liabilities
9,784
-3,538
-3,555
4,963
Change in fair value of convertible promissory notes
0
0
-4,093
8,032
Loss on convertible note conversions
0
0
-1,962
-772
Gain on exercise of warrant liabilities
-
-
0
5,369
Loss on issuance of registered direct common stock
0
0
0
-1
Loss on consideration shares and warrants
0
0
0
0
Loss on equity method investments
-
2
-35
-
Income from equity method investments
5
-
-
-
Expense for debt issuance costs due to fair value election on anson notes
0
0
0
0
Warrant issuance costs related to alvogen termination
-
-
0
0
Convertible note default penalty
-
-
0
0
Prepaid expense and other assets
1,812
-420
-451
-227
Account receivable
50
48
-36
-12
Accounts payable
-1,253
129
13
601
Insurance loan payable
-
-
-
0
Operating lease liabilities
-98
-102
-55
-63
Accrued expense and other liabilities
-232
-68
913
-210
Net cash used in operating activities
-8,875
-4,295
-3,713
-2,891
Business acquisition, net of cash acquired
-
-
-183
2,561
Cash used in investments
-
213
432
-
Purchase of property and equipment
897
-
-
-
Net cash used in investing activities
-684
-213
-249
-2,561
Repayment of convertible note
-
-
0
0
Repayment of insurance note
50
0
154
0
Expense for debt issuance costs due to fair value election on anson notes
0
0
0
0
Proceeds from issuance of common stock, net of issuance costs-ATMOffering
11,828
-
-
-
Proceeds from liability classified warrants
-
-
3,087
0
Proceeds from issuance of insurance loan
462
-
0
-225
Atm offering, net of offering costs
-
3,424
1,641
3,739
Proceeds from issuance of common stock, net of issuance costs-Underwritten Public Offering
20,716
-
-
-
Proceeds from issuance of common stock and warrants, net of issuance costs-Consideration Warrants
0
0
0
6,213
Proceeds from issuance of common stock and warrants, net of issuance costs-Warrants Other Than Consideration Warrants
-
0
0
0
Proceeds from issuance of common stock and warrants issued in private placement, net of issuance costs
-
-
0
0
Proceeds from anson convertible notes, net of oid
0
-
0
0
Net cash provided by financing activities
29,532
3,424
4,575
9,726
Net increase in cash and cash equivalents
19,973
-1,084
613
4,274
Cash and cash equivalents at beginning of period
6,713
7,797
7,200
-
Cash and cash equivalents at end of period
26,686
6,713
7,797
7,200
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock, net of...
$20,716K
Proceeds from issuance of
common stock, net of...
$11,828K
Proceeds from issuance of
insurance loan
$462K
(2.21%↑ Y/Y)
Net cash provided by
financing activities
$29,532K
(229.05%↑ Y/Y)
Canceled cashflow
$3,474K
Net increase in cash
and cash...
$19,973K
(1261.49%↑ Y/Y)
Canceled cashflow
$9,559K
something is missing
-$3,424K
Repayment of insurance
note
$50K
(-87.31%↓ Y/Y)
Change in fair value of
warrant liabilities
$9,784K
(178.11%↑ Y/Y)
Common stock issued in
exchange for services
$972K
(548.00%↑ Y/Y)
Stock-based compensation
$139K
(75.95%↑ Y/Y)
Amortization of operating
right of use assets
$102K
Depreciation and
amortization expense
$71K
Provision (recovery) for
expected credit losses
$25K
something is missing
$213K
Net cash used in
operating activities
-$8,875K
(-18.21%↓ Y/Y)
Net cash used in
investing activities
-$684K
Canceled cashflow
$11,093K
Canceled cashflow
$213K
Net loss
-$16,520K
(28.46%↑ Y/Y)
Purchase of property and
equipment
$897K
Prepaid expense and
other assets
$1,812K
(1068.98%↑ Y/Y)
Accounts payable
-$1,253K
(-150.10%↓ Y/Y)
Accrued expense and
other liabilities
-$232K
(-14.85%↓ Y/Y)
Operating lease
liabilities
-$98K
Account receivable
$50K
Income from equity
method investments
$5K
Buy us a coffee